Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director Nadja West sold 1,152 shares of Tenet Healthcare stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total transaction of $298,137.60. Following the completion of the transaction, the director directly owned 23,653 shares of the company’s stock, valued at $6,121,396.40. The trade was a 4.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Tenet Healthcare Stock Up 0.7%
Shares of NYSE:THC opened at $265.28 on Friday. The company has a market cap of $21.36 billion, a price-to-earnings ratio of 10.23, a PEG ratio of 1.00 and a beta of 1.23. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The company has a 50-day moving average price of $238.07 and a 200 day moving average price of $211.23.
Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities research analysts predict that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.
Institutional Trading of Tenet Healthcare
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the stock. UBS Group boosted their price objective on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research report on Monday, July 27th. The Goldman Sachs Group reiterated a “buy” rating and set a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday, July 28th. Truist Financial boosted their target price on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. Piper Sandler set a $308.00 price target on Tenet Healthcare in a research note on Monday, July 27th. Finally, Mizuho set a $290.00 price objective on Tenet Healthcare in a report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $273.00.
Check Out Our Latest Stock Analysis on Tenet Healthcare
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Articles
- Five stocks we like better than Tenet Healthcare
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
